MDA5+ levels in those patients showed a strong correlation with a primary but not a breakthrough (post-vaccination) SARS-CoV-2 infection, suggesting that vaccination may help prevent MDA5+-driven autoimmune responses, as well as reducing the risk for developing other autoimmune diseases (25, 66). The gene discussed is IFIH1; the disease is autoimmune disease.